These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32950830)

  • 41. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R;
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of montelukast in children with obstructive sleep apnea: a systematic review and meta-analysis.
    Ji T; Lu T; Qiu Y; Li X; Liu Y; Tai J; Guo Y; Zhang J; Wang S; Zhao J; Ni X; Xu Z
    Sleep Med; 2021 Feb; 78():193-201. PubMed ID: 33465554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Discussion on the treatment methods of pediatric obstructive sleep apnea hypopnea syndrome].
    Shen L; Lin Z; Xu Y; Yang Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):574-81. PubMed ID: 25257273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: a double-blind, randomized, placebo-controlled trial.
    Zhou B; He G; Liang J; Cheng L; Mehta A; Liu S; Yu W; Wang Z; Han D
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):88-94. PubMed ID: 26575524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relevance of the Mometasone furoate nasal spray in clinical practice.
    Ciprandi G; Varricchio A
    J Biol Regul Homeost Agents; 2018; 32(4):1051-1054. PubMed ID: 30043593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):272-9. PubMed ID: 18434976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Mometasone Furoate Cream Sodium Alginate Skin Repair Mask in Atopic Dermatitis Treatment.
    Ma H; Zhao Y; Xia X
    Altern Ther Health Med; 2024 Nov; 30(11):390-398. PubMed ID: 38430165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children].
    Modrzyński M; Zawisza E; Mazurek H
    Otolaryngol Pol; 2006; 60(4):543-50. PubMed ID: 17152807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis.
    Dalgic A; Dinc ME; Ulusoy S; Dizdar D; Is A; Topak M
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):213-216. PubMed ID: 28109729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Montelukast Sodium in Children with Adenoid Hypertrophy - A Comparative Study.
    Baruah B; Gupta A; Kumar A; Kumar A
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):306-310. PubMed ID: 37275091
    [No Abstract]   [Full Text] [Related]  

  • 54. Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis.
    Topuz B; Ogmen GG
    Clin Exp Allergy; 2003 Jun; 33(6):823-6. PubMed ID: 12801319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients.
    Drouin M; Yang WH; Bertrand B; Van Cauwenberge P; Clement P; Dalby K; Darnell R; Ernst TM; Hébert J; Karlsson G; Luciuk G; Mazza J; Roovers M; Ruoppi P; Seppey M; Stern M; Suonpää J; Sussman G; Tan KY; Tse K; Widjaja P; Jensen P; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):153-60. PubMed ID: 8760782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
    Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
    Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
    Bachert C; Mannent L; Naclerio RM; Mullol J; Ferguson BJ; Gevaert P; Hellings P; Jiao L; Wang L; Evans RR; Pirozzi G; Graham NM; Swanson B; Hamilton JD; Radin A; Gandhi NA; Stahl N; Yancopoulos GD; Sutherland ER
    JAMA; 2016 Feb; 315(5):469-79. PubMed ID: 26836729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis.
    Bende M; Carrillo T; Vóna I; da Castel-Branco MG; Arheden L
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):617-23. PubMed ID: 12086370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of mometasone furoate nasal spray on moderate-to-severe nasal congestion in seasonal allergic rhinitis: A responder analysis.
    Urdaneta E; Tunceli K; Gates D
    Allergy Asthma Proc; 2019 May; 40(3):173-179. PubMed ID: 31018892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.